日本医护人员重复接种SARS-CoV-2 mRNA疫苗后的免疫应答与IgG亚类动态
研究纳入19名完成七剂SARS-CoV-2 mRNA疫苗接种的日本医护人员,检测IgG亚类、中和抗体和细胞免疫应答。IgG1-3在第二剂后下降、第三剂后恢复,IgG4在第二剂后升高并保持稳定;抗Omicron XBB.1.5中和抗体在第二剂后不可测、第三剂后出现,第六和第七剂更新配方后进一步升高;细胞免疫全程稳定。提示重复mRNA接种增强体液免疫,无进行性IgG4升高或额外细胞免疫增强。
要点
- 重复mRNA接种增强体液免疫,IgG4无进行性升高。
- 抗XBB.1.5中和抗体在第三剂后出现,更新配方后进一步升高。
- 细胞免疫应答在整个接种过程中保持稳定。
核心结论
- 重复mRNA疫苗接种增强体液免疫,不引起IgG4进行性升高,也不额外增强细胞免疫应答。
研究设计与样本
- 研究纳入19名截至2024年4月完成七剂SARS-CoV-2 mRNA疫苗接种的日本医护人员。
- 血清和PBMCs分别于五个或三个时间点采集,检测IgG亚类、中和抗体和细胞应答。
主要发现
- IgG1-3水平在第二剂后下降、第三剂后恢复;IgG4在第二剂后升高并保持稳定。
- 抗Omicron XBB.1.5中和抗体在第二剂后不可测、第三剂后出现,第六和第七剂更新配方后进一步升高。
- 所有接种均为武汉株疫苗,细胞免疫全程保持稳定。
临床怎么用
- 支持重复mRNA疫苗接种以增强体液免疫,尤其针对变异株的中和抗体。
- 关注IgG4变化但无需担忧进行性升高,细胞免疫稳定提示免疫记忆维持。
局限性
- 样本量仅19名医护人员,结论外推需谨慎。
- 观察时间点有限,长期免疫动态未完全阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In Japan, many healthcare workers received up to seven doses of SARS-CoV-2 mRNA vaccines by April 2024. While repeated vaccination aims to strengthen immunity, concerns about immune imprinting and IgG subclass switching, particularly to IgG4, have arisen. This study examined 19 healthcare workers who completed seven doses. Serum and PBMCs collected at five or three time points respectively to measure were analyzed for IgG subclasses, neutralizing antibodies and cellular responses. IgG1-3 levels declined after the second dose but recovered after the third, whereas IgG4 increased post-second dose and remained stable. Neutralizing antibodies against Omicron XBB.1.5 were undetectable after two doses but appeared after the third, despite all being Wuhan strain vaccines, and rose further after the sixth and seventh doses with updated formulations. Cellular immunity remained stable throughout. These findings indicate repeated mRNA vaccination enhances humoral immunity without progressive IgG4 elevation or additional cellular response boosts.
引用
- Sano K, Kato H, Ryo A, et al. Immune response and IgG subclass dynamics following repeated SARS-CoV-2 mRNA vaccination in Japanese healthcare workers. Vaccine. 2026. PMID: 41759245. doi:10.1016/j.vaccine.2026.128396
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。